A phase I clinical study of VB4-845: Weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck

Overview of attention for article published in Drug Design, Development and Therapy, June 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 30 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 38 publications that cite this research output.

38

The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.

Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways

Article in International Journal of Molecular Sciences (April 2024)

Cancer stem cell biomarkers and related signalling pathways

Article in Journal of Drug Targeting (December 2023)

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside

Article in Cells (February 2022)